Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Lisa Baddi"'
Autor:
Ari Rosenberg, Theresa Ryan, Al B. Benson, Mary F. Mulcahy, Alfred Rademaker, Devalingam Mahalingam, Lisa Baddi, Howard S. Hochster, Thomas A. Hensing, Veena Shankaran
Publikováno v:
The Oncologist
Lessons Learned Adding docetaxel to the modified FOLFOX7 backbone (DOF) is a feasible three-drug combination therapy for advanced gastric cancer with high activity, providing evidence that leucovorin is not necessary in this setting. The DOF regimen
Publikováno v:
Annals of Cancer Research and Therapy. 11:15-30
Autor:
Lisa Baddi, D. W. Ray
Publikováno v:
Chest. 122:1077-1079
Autor:
Kenneth Offit, Yu Chen, Carole Oddoux, Lisa Baddi, Helen Huang, Diana S. Rosman, Loren S. Michel, Sharbani Phukan, Virginia G. Kaklamani, Habibul Ahsan, Junjian Liu, Ciarán Bradley, Boris Pasche, Alfred Rademaker, Harry Ostrer, Bree McDaniel, Chris Hegarty
Publikováno v:
Cancer research. 65(8)
There is growing evidence that common variants of the transforming growth factor-β (TGF-β) signaling pathway may modify breast cancer risk. In vitro studies have shown that some variants increase TGF-β signaling, whereas others have an opposite ef
Publikováno v:
The journal of supportive oncology. 3(1)
Autor:
Boris, Pasche, Thomas J, Knobloch, Yansong, Bian, Junjian, Liu, Sharbani, Phukan, Diana, Rosman, Virginia, Kaklamani, Lisa, Baddi, Farida S, Siddiqui, Wendy, Frankel, Thomas W, Prior, David E, Schuller, Amit, Agrawal, Jas, Lang, M Eileen, Dolan, Everett E, Vokes, William S, Lane, Chiang-Ching, Huang, Trinidad, Caldes, Antonio, Di Cristofano, Heather, Hampel, IngMarie, Nilsson, Gunnar, von Heijne, Riccardo, Fodde, V V V S, Murty, Albert, de la Chapelle, Christopher M, Weghorst
Publikováno v:
JAMA-Journal of the American Medical Association, 294(13), 1634-1646. American Medical Association
TGFBR1*6A is a common polymorphism of the type I transforming growth factor beta receptor (TGFBR1). Epidemiological studies suggest that TGFBR1*6A may act as a tumor susceptibility allele. How TGFBR1*6A contributes to cancer development is largely un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8050103421981c59190d8b5ea63a6f43
https://pure.eur.nl/en/publications/441618dc-7ac6-4829-a9ef-a2673d80813c
https://pure.eur.nl/en/publications/441618dc-7ac6-4829-a9ef-a2673d80813c
Autor:
Virginia, Kaklamani, Lisa, Baddi, Diana, Rosman, Junjian, Liu, Nathan, Ellis, Carole, Oddoux, Harry, Ostrer, Yu, Chen, Habibul, Ahsan, Kenneth, Offit, Boris, Pasche
Publikováno v:
BMC Genetics
Prostate cancer is the most commonly diagnosed cancer in men and one of the leading causes of cancer deaths. There is strong genetic evidence indicating that a large proportion of prostate cancers are caused by heritable factors but the search for pr
Autor:
Riccardo Fodde, M. Eileen Dolan, Wendy L. Frankel, Heather Hampel, Yansong Bian, Everett E. Vokes, David E. Schuller, Gunnar von Heijne, Jas C. Lang, Thomas J. Knobloch, Farida Siddiqui, Albert de la Chapelle, William S. Lane, IngMarie Nilsson, Christopher M. Weghorst, Boris Pasche, Trinidad Caldés, Amit Agrawal, Vundavalli V. Murty, Lisa Baddi, Junjian Liu, Sharbani Phukan, Virginia G. Kaklamani, Antonio Di Cristofano, Thomas W. Prior, Diana S. Rosman, Chiang Ching Huang
Publikováno v:
JAMA. 294:1634
ContextTGFBR1*6A is a common polymorphism of the type I transforming growth factor β receptor (TGFBR1). Epidemiological studies suggest that TGFBR1*6A may act as a tumor susceptibility allele. How TGFBR1*6A contributes to cancer development is large
Autor:
Boris Pasche, Diana S. Rosman, Yiansong Bian, Junjian Liu, Virginia G. Kaklamani, Christopher M. Weghorst, A de la Chapelle, Thomas J. Knobloch, Lisa Baddi
Publikováno v:
Journal of Clinical Oncology. 23:9511-9511
9511 Background: TGFBR1*6A is a common variant of the type I Transforming Growth Factor Beta receptor (TGFBR1). Epidemiological studies suggest that TGFBR1*6A may act as a common tumor susceptibili...
Autor:
Carole Oddoux, Boris Pasche, Virginia G. Kaklamani, Nathan A. Ellis, Diana S. Rosman, Habibul Ahsan, Lisa Baddi, Junjian Liu, Kenneth Offit, Harry Ostrer, Yu Chen
Publikováno v:
BMC Genetics. 5:28
Prostate cancer is the most commonly diagnosed cancer in men and one of the leading causes of cancer deaths. There is strong genetic evidence indicating that a large proportion of prostate cancers are caused by heritable factors but the search for pr